Literature DB >> 17983646

Rapid actions of androgens.

Guido Michels1, Uta C Hoppe.   

Abstract

The biological activity of androgens is thought to occur predominantly through binding to intracellular androgen-receptors, a member of the nuclear receptor family, that interact with specific nucleotide sequences to alter gene expression. This genomic-androgen effect typically takes at least more than half an hour. In contrast, the rapid or non-genomic actions of androgens are manifested within in seconds to few minutes. This rapid effect of androgens are manifold, ranging from activation of G-protein coupled membrane androgen-receptors or sex hormone-binding globulin receptors, stimulation of different protein kinases, to direct modulation of voltage- and ligand gated ion-channels and transporters. The physiological relevance of these non-genomic androgen actions has not yet been determined in detail. However, it may contribute to modulate several second messenger systems or transcription factors, which suggests a cross-talk between the fast non-genomic and the slow genomic pathway of androgens. This review will focus on the rapid effects of androgens on cell surface and cytoplasmic level.

Mesh:

Substances:

Year:  2007        PMID: 17983646     DOI: 10.1016/j.yfrne.2007.08.004

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  47 in total

1.  Progesterone receptor A (PRA) and PRB-independent effects of progesterone on gonadotropin-releasing hormone release.

Authors:  Nicole Sleiter; Yefei Pang; Cheryl Park; Teresa H Horton; Jing Dong; Peter Thomas; Jon E Levine
Journal:  Endocrinology       Date:  2009-05-07       Impact factor: 4.736

2.  Estrogens, androgens and generalized behavioral arousal in gonadectomized female and male C57BL/6 mice.

Authors:  Xi Chu; Khatuna Gagnidze; Donald Pfaff; Anders Ågmo
Journal:  Physiol Behav       Date:  2015-04-30

Review 3.  Sex steroidal hormones and respiratory control.

Authors:  Mary Behan; Julie M Wenninger
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

Review 4.  Androgens and esophageal cancer: What do we know?

Authors:  Olga A Sukocheva; Bin Li; Steven L Due; Damian J Hussey; David I Watson
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

5.  Opposite effects of dihydrotestosterone and estradiol on apoptosis in the anterior pituitary gland from male rats.

Authors:  María Laura Magri; María Florencia Gottardo; Sandra Zárate; Guadalupe Eijo; Jimena Ferraris; Gabriela Jaita; Mariela Moreno Ayala; Marianela Candolfi; Daniel Pisera; Adriana Seilicovich
Journal:  Endocrine       Date:  2015-08-22       Impact factor: 3.633

6.  Metformin inhibits androgen-induced IGF-IR up-regulation in prostate cancer cells by disrupting membrane-initiated androgen signaling.

Authors:  Roberta Malaguarnera; Antonella Sacco; Alaide Morcavallo; Sebastiano Squatrito; Antimo Migliaccio; Andrea Morrione; Marcello Maggiolini; Antonino Belfiore
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

7.  Expression of cAMP response element-binding protein in the duct system of the mouse submandibular gland.

Authors:  Sunisa Keattikunpairoj; Tomohiko Wakayama; Miyuki Yamamoto; Masa-aki Nakaya; Hiroki Nakata; Wiphawi Hipkaeo; Natthiya Sakulsak; Shoichi Iseki
Journal:  Histochem Cell Biol       Date:  2009-10-17       Impact factor: 4.304

8.  Testosterone and cholesterol vasodilation of rat aorta involves L-type calcium channel inhibition.

Authors:  E Alvarez; E Cairrão; M Morgado; C Morais; I Verde
Journal:  Adv Pharmacol Sci       Date:  2010-03-30

9.  Functional membrane androgen receptors in colon tumors trigger pro-apoptotic responses in vitro and reduce drastically tumor incidence in vivo.

Authors:  Shuchen Gu; Natalia Papadopoulou; Eva-Maria Gehring; Omaima Nasir; Konstantinos Dimas; Shefalee K Bhavsar; Michael Föller; Konstantinos Alevizopoulos; Florian Lang; Christos Stournaras
Journal:  Mol Cancer       Date:  2009-12-01       Impact factor: 27.401

10.  46,XY DSD with Female or Ambiguous External Genitalia at Birth due to Androgen Insensitivity Syndrome, 5alpha-Reductase-2 Deficiency, or 17beta-Hydroxysteroid Dehydrogenase Deficiency: A Review of Quality of Life Outcomes.

Authors:  Amy B Wisniewski; Tom Mazur
Journal:  Int J Pediatr Endocrinol       Date:  2009-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.